Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
bpV(bipy)
110
CHF
CHF 110.00
In stock
AG-CR1-0047-M0055 mgCHF 110.00
AG-CR1-0047-M02525 mgCHF 330.00
Product Details | |
---|---|
Synonyms | Potassium bisperoxo (bipyridine) oxovanadate (V) |
Product Type | Chemical |
Properties | |
Formula |
K[VO(O2)2C10H8N2] . 3H2O |
MW | 326.2 . 54.0 |
CAS | 1173697-60-3 | 42494-71-3 (anhydrous) |
Purity Chemicals | ≥98% (51V-NMR) |
Appearance | Yellow to orange crystalline solid. |
Solubility | Soluble in DMSO or water. |
Other Product Data |
Unstable in solution; reconstitute just prior to use. |
InChi Key | NPNSAGQTZNWMMR-UHFFFAOYSA-N |
Smiles | C1[N]2=CC=CC=C2C2=[N]1C=CC=C2 |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice | Protect from light. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Potent protein phosphotyrosine phosphatase inhibitor [1].
- Insulin mimetic in vitro and in vivo [1].
- PTEN inhibitor [2].
Product References
- Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics: B.I. Posner, et al.; J. Biol. Chem. 269, 4596 (1994)
- Bisperoxovanadium compounds are potent PTEN inhibitors: A.C. Schmid, et al.; FEBS Lett. 566, 35 (2004)